Solicitation for Public Comments, 28827-28828 [E8-11067]

Download as PDF Federal Register / Vol. 73, No. 97 / Monday, May 19, 2008 / Notices the public who wish to have printed material distributed to NVAC members should submit materials to the Executive Secretary, NVAC, through the contact person listed above prior to close of business May 30, 2008. Preregistration is required for both public attendance and comment. Any individual who wishes to attend the meeting and/or participate in the public comment session should e-mail nvpo@hhs.gov or call 202–690–5566. Dated: May 12, 2008. Bruce Gellin, Director, National Vaccine Program Office. [FR Doc. E8–11065 Filed 5–16–08; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Announcement of Third Meeting of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020 Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science, Office of Disease Prevention and Health Promotion. ACTION: Notice of meeting. AGENCY: pwalker on PROD1PC71 with NOTICES Authority: 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended. The Committee is governed by the provision of Public Law 92–463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. SUMMARY: The U.S. Department of Health and Human Services (HHS) announces the third meeting of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020. All Committee meetings are open to the public. The Committee will review the nation’s health promotion and disease prevention objectives and efforts to develop goals and objectives to improve the health status and reduce health risks for Americans by the year 2020. The Committee will provide to the Secretary of Health and Human Services advice and consultation to facilitate the process for developing and implementing the next iteration of national health promotion and disease prevention goals and objectives and provide advice for initiatives to occur during the initial implementation phase of the goals and objectives. HHS will use the advice that is provided to develop recommendations to form the national health promotion and disease prevention objectives for 2020 and the process for implementing the objectives. VerDate Aug<31>2005 17:18 May 16, 2008 Jkt 214001 The intent is to develop and launch objectives designed to improve the health status and reduce health risks for Americans by the year 2020. DATES: The Committee will meet on Thursday, June 5, 2008 from 9 a.m. until 5:30 p.m., and Friday, June 6, 2008 from 9 a.m. until 4:30 p.m. ADDRESSES: The meeting will be held at the Hyatt Regency Crystal City at Reagan National Airport, located at 2799 Jefferson Davis Highway, Arlington, Virginia 22202. FOR FURTHER INFORMATION CONTACT: Carter Blakey, Designated Federal Officer, Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020, U.S. Department of Health and Human Services, Office of Public Health and Science, Office of Disease Prevention and Health Promotion, 1101 Wootton Parkway, Room LL–100, Rockville, MD 20852, (240) 453–8254 (telephone), (240) 453–8281 (fax). Additional information is available on the Internet at http://www.healthypeople.gov. Registration questions may be directed to Hilary Scherer at HP2020@norc.org (e-mail), (301) 634–9374 (phone), or (301) 634–9301 (fax). SUPPLEMENTARY INFORMATION: The names of the 13 members of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020 are available at http:// www.healthypeople.gov. Purpose of Meeting: The Committee will consider the work of its various subcommittees, hear presentations on select topics, and deliberate next steps. The Committee will also hear oral comments from the public to help inform them as they prepare their recommendations to the Secretary. Every 10 years, through the Healthy People initiative, HHS leverages scientific insights and lessons from the past decade, along with the new knowledge of current data, trends, and innovations to develop the next iteration of national health promotion and disease prevention objectives. Healthy People provides science-based, 10-year national objectives for promoting health and preventing disease. Healthy People 2020 will reflect assessments of major risks to health and wellness, changing public health priorities, and emerging technologies related to our nation’s health preparedness and prevention. Public Participation at Meeting: Members of the public are invited to observe the Committee meeting. A portion of the meeting agenda will be allocated for committee members to PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 28827 hear public comments. All individuals wishing to observe and/or make comments must pre-register at http:// www.healthypeople.gov. Due to time constraints, a limited number of scheduled time slots for public comments will be available on a firstcome-first-served basis through preregistration. Comments will also be limited to 1–2 minutes per individual. Attendees that do not pre-register to make comments cannot be guaranteed an opportunity to have his or her comments heard during the meeting. Individuals are encouraged to submit their comments in writing in advance of the meeting through the pre-registration process. Written comments are also welcome throughout the development process of the national health promotion and disease prevention objectives for 2020. They can be submitted through the Healthy People Web site at: http:// www.healthypeople.gov/hp2020/ comments/ or they can be e-mailed to HP2020@hhs.gov. Registrations must be completed by 5:30 p.m. EST on Monday, June 2, 2008. Space for the meeting is limited. Registrations will be accepted until maximum room capacity is reached. A waiting list will be maintained should registrations exceed room capacity. Individuals on the waiting list will be contacted as additional space for the meeting becomes available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person. Dated: May 13, 2008. Penelope Slade Royall, RADM, USPHS, Deputy Assistant Secretary for Health (Disease Prevention and Health Promotion), Office of Disease Prevention and Health Promotion. [FR Doc. E8–11071 Filed 5–16–08; 8:45 am] BILLING CODE 4150–32–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Solicitation for Public Comments Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science. ACTION: Notice. AGENCY: SUMMARY: The Department of Health and Human Services (DHHS) is hereby giving notice that the National Vaccine Program Office (NVPO) is seeking comments on a draft document that has been prepared for presentation to the National Vaccine Advisory Committee (NVAC). E:\FR\FM\19MYN1.SGM 19MYN1 28828 Federal Register / Vol. 73, No. 97 / Monday, May 19, 2008 / Notices NVPO is organizationally located within the Office of Public Health and Science within the Office of the Secretary of the Department of Health and Human Services. NVPO has responsibility for coordinating and ensuring collaboration among the many Federal agencies involved in vaccine and immunization activities. NVAC is a statutory Federal advisory committee. Establishment of the Committee was authorized under Section 2105 of the Public Health Service Act, as amended (42 U.S.C. Section 300aa–5). NVAC provides advice and makes recommendations to the Director of the National Vaccine Program on matters related to the Program. The Assistant Secretary for Health serves as Director of the National Vaccine Program. Management support for the Committee’s activities is provided by the NVPO. The NVAC charter stipulates that the Committee can utilize subcommittees and working groups to provide assistance in carrying out its function. NVAC has established four working groups for this purpose. The Adolescent Immunization Working Group was established and has been charged to develop a series of recommendations for the programmatic and financial implementation of adolescent immunization recommendations. To comply with its charge, this Working Group has developed draft recommendations for adolescent immunization that are to be presented to NVAC for discussion in an open public session. To enhance public involvement in development of the recommendations, an opportunity is being given for the public to provide comment. The draft document can be viewed and downloaded from the NVAC Web site at http://www.hhs.gov/ nvpo/nvac/index.html. Consideration will be given to the comments received for changes to be made to the draft recommendations. The draft recommendations will be presented to NVAC for discussion in an open public session. All comments on the draft recommendations should be received no later than 5 p.m. on May 29, 2008. Comments should be sent to Shannon Stokley, MPH; Health Services Research and Evaluation Branch, Immunization Services Division; Centers for Disease Control and Prevention. Comments should be sent by e-mail to sstokley@cdc.gov or fax at (404) 639– 8614. pwalker on PROD1PC71 with NOTICES SUPPLEMENTARY INFORMATION: FOR FURTHER INFORMATION CONTACT: Shannon Stokley, MPH; Health Services VerDate Aug<31>2005 17:18 May 16, 2008 Jkt 214001 Research and Evaluation Branch, Immunization Services Division; National Center for Immunization and Respiratory Diseases; Centers for Disease Control; (404) 639–8734. Dated: May 12, 2008. Bruce Gellin, Director, National Vaccine Program Office. [FR Doc. E8–11067 Filed 5–16–08; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Board of Scientific Counselors, National Institute of Mental Health. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Institute of Mental Health, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors, National Institute of Mental Health. Date: June 9–11, 2008. Time: June 9, 2008, 7 p.m. to 10 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Time: June 10, 2008, 8:30 a.m. to 11:50 a.m. Agenda: To review and evaluate the Section on Molecular Neurobiology, Unit on Neural Function, and Section on Functional Neuroanatomy. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Time: June 10, 2008, 12 p.m. to 1 p.m. Agenda: To review and evaluate the Training Fellows and Staff Scientists. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Time: June 10, 2008, 1 p.m. to 4 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Time: June 10, 2008, 7 p.m. to 10 p.m. PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Time: June 11, 2008, 8:30 a.m. to 11:40 a.m. Agenda: To review and evaluate the Section on Neuroadaptation and Protein Metabolism, Unit on Affective Psychophysiology, and Unit on Genetics of Mood and Anxiety Disorders. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Conference Room C, Rockville, MD 20852. Time: June 11, 2008, 11:50 a.m. to 12:50 p.m. Agenda: To review and evaluate the Training Fellows and Staff Scientists. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Conference Room C, Rockville, MD 20852. Time: June 11, 2008, 1:20 p.m. to 4 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Conference Room C, Rockville, MD 20852. Contact Person: Emily E. Gross, Program Assistant, Office of the Scientific Director, National Institute of Mental Health, NIH, 9000 Rockville Pike, Building 10, Room 4N222, Bethesda, MD 20892, 301–402–4137, grosse@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS) Dated: May 9, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–11088 Filed 5–16–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and E:\FR\FM\19MYN1.SGM 19MYN1

Agencies

[Federal Register Volume 73, Number 97 (Monday, May 19, 2008)]
[Notices]
[Pages 28827-28828]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-11067]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Solicitation for Public Comments

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of Public Health and Science.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (DHHS) is hereby 
giving notice that the National Vaccine Program Office (NVPO) is 
seeking comments on a draft document that has been prepared for 
presentation to the National Vaccine Advisory Committee (NVAC).

[[Page 28828]]


SUPPLEMENTARY INFORMATION: NVPO is organizationally located within the 
Office of Public Health and Science within the Office of the Secretary 
of the Department of Health and Human Services. NVPO has responsibility 
for coordinating and ensuring collaboration among the many Federal 
agencies involved in vaccine and immunization activities.
    NVAC is a statutory Federal advisory committee. Establishment of 
the Committee was authorized under Section 2105 of the Public Health 
Service Act, as amended (42 U.S.C. Section 300aa-5). NVAC provides 
advice and makes recommendations to the Director of the National 
Vaccine Program on matters related to the Program. The Assistant 
Secretary for Health serves as Director of the National Vaccine 
Program. Management support for the Committee's activities is provided 
by the NVPO.
    The NVAC charter stipulates that the Committee can utilize 
subcommittees and working groups to provide assistance in carrying out 
its function. NVAC has established four working groups for this 
purpose.
    The Adolescent Immunization Working Group was established and has 
been charged to develop a series of recommendations for the 
programmatic and financial implementation of adolescent immunization 
recommendations. To comply with its charge, this Working Group has 
developed draft recommendations for adolescent immunization that are to 
be presented to NVAC for discussion in an open public session. To 
enhance public involvement in development of the recommendations, an 
opportunity is being given for the public to provide comment. The draft 
document can be viewed and downloaded from the NVAC Web site at http://
www.hhs.gov/nvpo/nvac/index.html. Consideration will be given to the 
comments received for changes to be made to the draft recommendations. 
The draft recommendations will be presented to NVAC for discussion in 
an open public session.
    All comments on the draft recommendations should be received no 
later than 5 p.m. on May 29, 2008. Comments should be sent to Shannon 
Stokley, MPH; Health Services Research and Evaluation Branch, 
Immunization Services Division; Centers for Disease Control and 
Prevention. Comments should be sent by e-mail to sstokley@cdc.gov or 
fax at (404) 639-8614.

FOR FURTHER INFORMATION CONTACT: Shannon Stokley, MPH; Health Services 
Research and Evaluation Branch, Immunization Services Division; 
National Center for Immunization and Respiratory Diseases; Centers for 
Disease Control; (404) 639-8734.

    Dated: May 12, 2008.
Bruce Gellin,
Director, National Vaccine Program Office.
 [FR Doc. E8-11067 Filed 5-16-08; 8:45 am]
BILLING CODE 4150-44-P